Search for: "Gilead Sciences, Inc.," Results 21 - 40 of 181
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jan 2022, 4:15 am by IPWatchdog
District Court for the Eastern District of New York yesterday unsealed documents in an anticounterfeiting suit filed last year by Gilead Sciences, Inc. against a slew of defendants who Gilead alleges sold, marketed, and distributed counterfeits of its HIV medications. [read post]
19 Jan 2022, 4:15 am by IPWatchdog
District Court for the Eastern District of New York yesterday unsealed documents in an anticounterfeiting suit filed last year by Gilead Sciences, Inc. against a slew of defendants who Gilead alleges sold, marketed, and distributed counterfeits of its HIV medications. [read post]
14 Sep 2021, 4:00 am by Alan Macek
Gilead Sciences Canada, Inc., 2021 FCA 122, the Federal Court of Appeal considered when summary determination is appropriate, particularly when a responding party has moved to quash the motion for summary trial. [read post]
13 Aug 2021, 4:00 am by Jim Sedor
Rand Paul revealed his wife bought stock in Gilead Sciences, which makes an antiviral drug used to treat COVID-19, in February 2020, before it was classified as a pandemic by the World Health Organization. [read post]
24 Jul 2021, 8:14 pm by Patent Docs
Borello of Venable LLP will moderate a panel consisting of Tashica Amirgholizadeh of Gilead Sciences, Inc.; Danielle A. [read post]
19 Apr 2021, 1:30 pm by Sherry Knowles
On April 7, 2021, the European Patent Office (EPO) Opposition Division (OD) issued a comprehensive written decision in the Opposition by Gilead Sciences, Inc. against NuCana plc’s European Patent No. [read post]
19 Apr 2021, 1:30 pm by Sherry Knowles
On April 7, 2021, the European Patent Office (EPO) Opposition Division (OD) issued a comprehensive written decision in the Opposition by Gilead Sciences, Inc. against NuCana plc’s European Patent No. [read post]
17 Mar 2021, 4:00 am by Alan Macek
Gilead Sciences Canada, Inc., 2020 FC 486. [read post]
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
This particular case involved a new generation of drugs for the treatment of hepatitis C, where Idenix accused Gilead Sciences, Inc. [read post]
15 Dec 2020, 6:06 am
Gilead Sciences, Inc., a group of Gilead stockholders sought to inspect corporate documents for the purpose of investigating wrongdoing in the development and marketing of HIV drugs. [read post]